Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marian A Rollins-Raval

Showing results (31-40 of 53) with videos related to

Pageof 6
Sort By:
Journal of Clinical Apheresis|August 9, 2020
A strategy to conserve personal protective equipment while performing therapeutic plasma exchange in a patient with COVID-19Chelsea Reyes, Cynthia J Ornelas, Marian A Rollins-Raval, et al.
Blood Research|July 17, 2019
The top 10 things to know about transfusion medicine before intern year: an evidence-based course for graduating medical studentsAlexis R Peedin, Irina Perjar, Marshall A Mazepa, et al.
Journal of Clinical Medicine Research|February 9, 2023
Reduced Time to Procedure for Gastrointestinal Bleeding After Warfarin Reversal With Four-Factor Complex Concentrate as Compared to PlasmaHannah Spector, Hannah L McRae, Tanzy Love, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|September 5, 2018
Predictive Value of Schistocytes in Recurrence of Acquired Thrombotic Thrombocytopenic Purpura With Severe ADAMTS13 Deficiency at Discontinuation of Daily Therapeutic Plasma ExchangeAlexis R Peedin, Yara A Park, Marshall A Mazepa, et al.
Transfusion|September 13, 2018
ADAMTS13: origins, applications, and prospectsWilliam E Plautz, Jay S Raval, Mitchell R Dyer, et al.
Transfusion|June 2, 2020
Von Willebrand factor as a thrombotic and inflammatory mediator in critical illnessWilliam E Plautz, Zachary A Matthay, Marian A Rollins-Raval, et al.
Clinical Laboratory|September 19, 2019
Revisiting Bone Marrow Core Biopsy Adequacy Criteria in the Era of Extensive Ancillary TestingStacey S O'Neill, Tammy C Wong, Jeremy Parris, et al.
Transfusion|May 7, 2020
Viscoelastic testing in COVID-19: a possible screening tool for severe disease?Jay S Raval, Allison E Burnett, Marian A Rollins-Raval, et al.
Journal of Clinical Apheresis|November 8, 2019
Heparin-induced thrombocytopenia associated with collection of hematopoietic progenitor cells by apheresisJay S Raval, Yara A Park, Irina Perjar, et al.
Transfusion|March 24, 2026
Multiple consecutive daily therapeutic plasma exchange using exclusively albumin replacement fluid in low bleeding risk patients is associated with only rare and mild bleedsJay S Raval, Joseph R Griggs, Andres E Mindiola Romero, et al.
Pageof 6

Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
Journal of Clinical Apheresis|August 9, 2020
A strategy to conserve personal protective equipment while performing therapeutic plasma exchange in a patient with COVID-19Chelsea Reyes, Cynthia J Ornelas, Marian A Rollins-Raval, et al.
Blood Research|July 17, 2019
The top 10 things to know about transfusion medicine before intern year: an evidence-based course for graduating medical studentsAlexis R Peedin, Irina Perjar, Marshall A Mazepa, et al.
Journal of Clinical Medicine Research|February 9, 2023
Reduced Time to Procedure for Gastrointestinal Bleeding After Warfarin Reversal With Four-Factor Complex Concentrate as Compared to PlasmaHannah Spector, Hannah L McRae, Tanzy Love, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|September 5, 2018
Predictive Value of Schistocytes in Recurrence of Acquired Thrombotic Thrombocytopenic Purpura With Severe ADAMTS13 Deficiency at Discontinuation of Daily Therapeutic Plasma ExchangeAlexis R Peedin, Yara A Park, Marshall A Mazepa, et al.
Transfusion|September 13, 2018
ADAMTS13: origins, applications, and prospectsWilliam E Plautz, Jay S Raval, Mitchell R Dyer, et al.
Transfusion|June 2, 2020
Von Willebrand factor as a thrombotic and inflammatory mediator in critical illnessWilliam E Plautz, Zachary A Matthay, Marian A Rollins-Raval, et al.
Clinical Laboratory|September 19, 2019
Revisiting Bone Marrow Core Biopsy Adequacy Criteria in the Era of Extensive Ancillary TestingStacey S O'Neill, Tammy C Wong, Jeremy Parris, et al.
Transfusion|May 7, 2020
Viscoelastic testing in COVID-19: a possible screening tool for severe disease?Jay S Raval, Allison E Burnett, Marian A Rollins-Raval, et al.
Journal of Clinical Apheresis|November 8, 2019
Heparin-induced thrombocytopenia associated with collection of hematopoietic progenitor cells by apheresisJay S Raval, Yara A Park, Irina Perjar, et al.
Transfusion|March 24, 2026
Multiple consecutive daily therapeutic plasma exchange using exclusively albumin replacement fluid in low bleeding risk patients is associated with only rare and mild bleedsJay S Raval, Joseph R Griggs, Andres E Mindiola Romero, et al.
Pageof 6